KHAN aLASSAL

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about KHAN aLASSAL

Is KHAN aLASSAL on an FDA import alert?

Yes. As of October 26, 2026, KHAN aLASSAL is on the red list of FDA Import Alert 54-16, “Foods/supplements with active pharmaceutical ingredient”, for gold herbs royal king honey with herbal extracts; vitamins/minerals (human/animal); proteins/unconv dietary supp (human); FDA published the listing on May 10, 2019.

Has FDA refused shipments from KHAN aLASSAL?

Yes. FDA refused 1 shipment line from KHAN aLASSAL on March 4, 2019. The most recent, on March 4, 2019, was honey, charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse KHAN aLASSAL's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

What is KHAN aLASSAL's FEI number?

KHAN aLASSAL's FDA Establishment Identifier (FEI) is 3014847130.

Can shipments from KHAN aLASSAL still enter the U.S.?

Shipments of gold herbs royal king honey with herbal extracts; vitamins/minerals (human/animal); proteins/unconv dietary supp (human) from KHAN aLASSAL can be detained without physical examination under Import Alert 54-16; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).